Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2024-04-28 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
2023年度独立董事履职报告 （易兰广）
Board/Management Information Classification · 95% confidence The document is titled as the "2023年度独立董事履职报告（易兰广）" which translates to "2023 Annual Independent Director's Performance Report (Yi Languang)". It is a detailed report by an independent director about their duties, attendance, committee participation, communication with auditors, and oversight activities during the year 2023. The content focuses on governance, compliance, audit committee activities, and independent director responsibilities rather than financial results or earnings. It is not an annual report (10-K), audit report (AR), or earnings release (ER). It is a governance-related report detailing the independent director's role and activities, which fits best under Board/Management Information (MANG) as it relates to board member duties and governance activities. The document length is about 5096 characters, which is substantive and not a mere announcement or certification. Therefore, the classification is MANG with high confidence.
2024-04-28 Chinese
关于益丰大药房连锁股份有限公司非经营性资金占用及其他关联资金往来情况的专项审计报告
Regulatory Filings
2024-04-28 Chinese
战略与可持续发展委员会议事规则
Governance Information Classification · 100% confidence The document is titled as the "Board of Directors Strategic and Sustainable Development Committee Rules" of a company. It details the composition, responsibilities, meeting procedures, and governance related to a board committee focused on strategy and ESG (Environmental, Social, and Governance) matters. There are no financial statements, earnings data, or regulatory filings such as audit reports or annual reports. The document is a governance-related internal rules document for a board committee. It does not announce a report publication nor is it a brief announcement. It fits the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2024-04-28 Chinese
益丰药房关于2023年日常关联交易确认及2024年日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Yifeng Pharmacy Chain Co., Ltd. regarding the confirmation of daily related party transactions for the year 2023 and the forecast for 2024. It includes details about the approval by the board of directors, the nature and amounts of related party transactions, pricing policies, and the impact on the company. The document is a formal disclosure about related party transactions, which is a regulatory announcement to inform shareholders and the market about these transactions. It does not contain financial statements or detailed financial performance data, nor is it a report like an annual or interim report. The document is relatively short (4105 characters) and serves as an announcement of related party transactions rather than a full report. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-04-28 Chinese
益丰药房募集资金年度存放与使用情况鉴证报告
Regulatory Filings
2024-04-28 Chinese
中信证券股份有限公司关于益丰大药房连锁股份有限公司2023年度募集资金存放与使用情况的专项核查意见
Regulatory Filings
2024-04-28 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.